While Ozempic and retatrutide share the common goal of weight loss and improving cardiometabolic health, the unique triple-hormone receptor agonism of retatrutide sets it apart, offering the potential for more substantial and sustained weight reduction
Lanfer A, Knof K, Barba G, Veidebaum T, Papoutsou S, de Henauw S, et al
Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials
IGNITE YOUR METABOLISM
At the end of the 20th century, endocrinologist Daniel Drucker was looking for a hormone similar enough to the human gut's GLP-1, which would have similar appetite-suppressing and blood sugar-regulating qualities, without being broken down by the human body so quickly